
S14.E2: My Life on GLP1 - What Your Side Effects are Really Telling You
Struggling with nausea, fatigue, or digestive issues on Ozempic, Wegovy, or Mounjaro? This episode explains what GLP-1 side effects really mean, when they'll stop, and how to manage them effectively. ...
8 Des 202510min

S14.E1: My Life on GLP1 - Navigating the Appetite Return
Experiencing hunger again after months on Ozempic, Wegovy, or Mounjaro? You're not alone. This episode breaks down why appetite returns during GLP-1 treatment, what it means for your weight loss journ...
8 Des 202510min

My Life On GLP-1: Series 14 Trailer
My Life on GLP-1 is returning for Series 14 next week! Get the straight facts on weight loss meds, GLP-1 breakthroughs, side effects, success stories, and helpful tips. Whether you're on Ozempic, Moun...
4 Des 20251min

My Life On GLP-1: Thanksgiving Holiday Special - Weight Gain Fear with Holiday Indulgences
Afraid of weight gain on Thanksgiving despite taking GLP-1 medications like Ozempic, Zepbound, or Mounjaro? You're not alone. Discover why holiday weight gain happens even with weight loss medication,...
19 Nov 202510min

S13.E8: My Life On GLP1 - Why Am I Always Cold? (Finally Explained + Real Fixes)
Wearing fleece in 70-degree weather? You're not alone. Discover why semaglutide and tirzepatide cause "Ozempic chill"—from brown adipose tissue changes to metabolic slowdown. Learn 2025 research on hy...
30 Okt 20258min

S13.E7: My Life On GLP1 - Muscle Loss: Sarcopenia Risk & Proven Fixes
25-40% of weight lost on semaglutide and tirzepatide comes from muscle, not fat. Learn about sarcopenia, DXA scan data revealing lean mass loss, and 5 essential strategies: protein targets, resistance...
30 Okt 20257min

S13.E6: My Life On GLP1 - Geographic Use (US, UK, Canada): Where GLP1 Meds Are Exploding
Why Rhode Island leads 67% growth while Arkansas declines. Map state-by-state, province-by-province GLP-1 adoption patterns across North America and UK. Learn which regions have best access, why postc...
29 Okt 20258min

S13.E5: My Life On GLP1 - Mounjaro & Fatty Liver Disease: Groundbreaking Research
74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans w...
29 Okt 20256min




















